Medtronic: Strategy, Not Tax, Behind Covidien Deal
Medtronic Inc’s Chief Executive Omar Ishrak has insisted that the company’s USD42.9bn deal to acquire Dublin-based Covidien Plc, and, thereby, move its tax residence from the United States to Ireland in a “corporate inversion,” is based on business logic and not corporate tax reduction. Medtronic is among a number of… – Continue reading